255 related articles for article (PubMed ID: 25064726)
1. Influence of the physiological variability of fasted gastric pH and tablet retention time on the variability of in vitro dissolution and simulated plasma profiles.
Kovačič NN; Pišlar M; Ilić I; Mrhar A; Bogataj M
Int J Pharm; 2014 Oct; 473(1-2):552-9. PubMed ID: 25064726
[TBL] [Abstract][Full Text] [Related]
2. The Influence of Simulated Fasted Gastrointestinal pH Profiles on Diclofenac Sodium Dissolution in a Glass-Bead Flow-Through System.
Felicijan T; Pišlar M; Vene K; Bogataj M
AAPS PharmSciTech; 2018 Oct; 19(7):2875-2884. PubMed ID: 30151730
[TBL] [Abstract][Full Text] [Related]
3. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
Kambayashi A; Blume H; Dressman J
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
[TBL] [Abstract][Full Text] [Related]
4. Modulation of microenvironmental pH for dual release and reduced in vivo gastrointestinal bleeding of aceclofenac using hydroxypropyl methylcellulose-based bilayered matrix tablet.
Kang WH; Nguyen HV; Park C; Choi YW; Lee BJ
Eur J Pharm Sci; 2017 May; 102():85-93. PubMed ID: 28263912
[TBL] [Abstract][Full Text] [Related]
5. Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses.
Garbacz G; Wedemeyer RS; Nagel S; Giessmann T; Mönnikes H; Wilson CG; Siegmund W; Weitschies W
Eur J Pharm Biopharm; 2008 Oct; 70(2):421-8. PubMed ID: 18582568
[TBL] [Abstract][Full Text] [Related]
6. The role of individual gastric emptying of pellets in the prediction of diclofenac in vivo dissolution.
Klein S; Garbacz G; Pišlar M; Locatelli I; Liu C; Weitschies W; Siegmund W; Mrhar A; Bogataj M
J Control Release; 2013 Mar; 166(3):286-93. PubMed ID: 23306025
[TBL] [Abstract][Full Text] [Related]
7. Predicting the oral pharmacokinetic profiles of multiple-unit (pellet) dosage forms using a modeling and simulation approach coupled with biorelevant dissolution testing: case example diclofenac sodium.
Kambayashi A; Blume H; Dressman JB
Eur J Pharm Biopharm; 2014 Jul; 87(2):236-43. PubMed ID: 24462791
[TBL] [Abstract][Full Text] [Related]
8. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
Franek F; Holm P; Larsen F; Steffansen B
Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
[TBL] [Abstract][Full Text] [Related]
9. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
[TBL] [Abstract][Full Text] [Related]
10. Report: in vitro dissolution studies of different brands of sustained release diclofenac sodium matrix tablet available in Bangladesh.
Abdullah MD; Bepary S; Rouf AS
Pak J Pharm Sci; 2008 Jan; 21(1):70-7. PubMed ID: 18166523
[TBL] [Abstract][Full Text] [Related]
11. Release of poorly soluble drugs from HPMC tablets studied by FTIR imaging and flow-through dissolution tests.
van der Weerd J; Kazarian SG
J Pharm Sci; 2005 Sep; 94(9):2096-109. PubMed ID: 16052556
[TBL] [Abstract][Full Text] [Related]
12. Dissolution parameters for sodium diclofenac-containing hypromellose matrix tablet.
Mourão SC; da Silva C; Bresolin TM; Serra CH; Porta V
Int J Pharm; 2010 Feb; 386(1-2):201-7. PubMed ID: 19941944
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal and Systemic Disposition of Diclofenac under Fasted and Fed State Conditions Supporting the Evaluation of in Vitro Predictive Tools.
Van Den Abeele J; Schilderink R; Schneider F; Mols R; Minekus M; Weitschies W; Brouwers J; Tack J; Augustijns P
Mol Pharm; 2017 Dec; 14(12):4220-4232. PubMed ID: 28621952
[TBL] [Abstract][Full Text] [Related]
14. Enzymatic degradation of cross-linked high amylose starch tablets and its effect on in vitro release of sodium diclofenac.
Rahmouni M; Chouinard F; Nekka F; Lenaerts V; Leroux JC
Eur J Pharm Biopharm; 2001 May; 51(3):191-8. PubMed ID: 11343882
[TBL] [Abstract][Full Text] [Related]
15. Floating gastroretentive drug delivery systems: Comparison of experimental and simulated dissolution profiles and floatation behavior.
Eberle VA; Schoelkopf J; Gane PA; Alles R; Huwyler J; Puchkov M
Eur J Pharm Sci; 2014 Jul; 58():34-43. PubMed ID: 24704154
[TBL] [Abstract][Full Text] [Related]
16. The influence of gastric emptying kinetics on the drug release from enteric coated pellets in fasted state: an in vitro/in vivo correlation.
Stefanič M; Locatelli I; Vrečer F; Sever T; Mrhar A; Bogataj M
Eur J Pharm Biopharm; 2012 Oct; 82(2):376-82. PubMed ID: 22884655
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of food effect on the oral absorption of clarithromycin from immediate release tablet using physiological modelling.
Radwan A; Jayyousi R; Shraim N; Zaid AN
Biopharm Drug Dispos; 2019 Apr; 40(3-4):121-134. PubMed ID: 30891805
[TBL] [Abstract][Full Text] [Related]
18. Modeling and comparison of release profiles: Effect of the dissolution method.
Cascone S
Eur J Pharm Sci; 2017 Aug; 106():352-361. PubMed ID: 28627469
[TBL] [Abstract][Full Text] [Related]
19. In Vitro-In Vivo Predictive Dissolution-Permeation-Absorption Dynamics of Highly Permeable Drug Extended-Release Tablets via Drug Dissolution/Absorption Simulating System and pH Alteration.
Li ZQ; Tian S; Gu H; Wu ZG; Nyagblordzro M; Feng G; He X
AAPS PharmSciTech; 2018 May; 19(4):1882-1893. PubMed ID: 29663288
[TBL] [Abstract][Full Text] [Related]
20. In vivo/in vitro correlations for four differently dissolving ketorolac tablets.
Gordon MS; Chowhan Z
Biopharm Drug Dispos; 1996 Aug; 17(6):481-92. PubMed ID: 8866039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
